Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 

Abstract/Editors' Note | Full Text | PDF

FIGURES/TABLES SUMMARY PAGE

PowerPoint slides are available for most Figures at Annals.org

Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease


View this table:

[in a new window]
 
Table 1. U.S. Preventive Services Task Force Categories for Rating Internal Validity of Studies

 

View this table:

[in a new window]
 
Table 2. Meta-Analysis Summary Table

 


View larger version (21K):

[in a new window]
 
Figure 1. Relative risk or odds ratio for cardiovascular disease mortality. Error bars represent 95% CIs. HRT = hormone replacement therapy. "Current," "past," and "ever" use are categories used in the individual studies. "Any use" is a category created for this meta-analysis combining data from studies evaluating ever and never use of HRT with data from studies evaluating current, past, or never use (current + past + ever use).

 


View larger version (18K):

[in a new window]
 
Figure 2. Relative risk or odds ratio for coronary artery disease mortality. Error bars represent 95% CIs. HRT = hormone replacement therapy. "Current," "past," and "ever" use are categories used in the individual studies. "Any use" is a category created for this meta-analysis combining data from studies evaluating ever and never use of HRT with data from studies evaluating current, past, or never use (current + past + ever use).

 


View larger version (16K):

[in a new window]
 
Figure 3. Relative risk or odds ratio for cardiovascular disease incidence. Error bars represent 95% CIs. Reference 47 is pooled data from a previously published meta-analysis. HRT = hormone replacement therapy. "Current," "past," and "ever" use are categories used in the individual studies. "Any use" is a category created for this meta-analysis combining data from studies evaluating ever and never use of HRT with data from studies evaluating current, past, or never use (current + past + ever use).

 


View larger version (29K):

[in a new window]
 
Figure 4. Relative risk or odds ratio for coronary artery disease incidence. Error bars represent 95% CIs. HRT = hormone replacement therapy; RCT = randomized, controlled trial; SES = socioeconomic status. "Current," "past," and "ever" use are categories used in the individual studies. "Any use" is a category created for this meta-analysis combining data from studies evaluating ever and never use of HRT with data from studies evaluating current, past, or never use (current + past + ever use). Adjustments for SES were adjustments as assessed by social class (12, 13), education (14, 15), and income.

 

View this table:

[in a new window]
 
Table 3. Coronary Artery Disease Incidence and Hormone Replacement Therapy

 


View larger version (31K):

[in a new window]
 
Appendix Figure. Search methods and results. HRT = hormone replacement therapy; RCT = randomized, controlled trial.

 

View this table:

[in a new window]
 
Appendix Table 1. Characterization of Hormone Replacement Therapy Use in Case-Control Studies: Assessment and Definitions

 

View this table:

[in a new window]
 
Appendix Table 2. Characterization of Hormone Replacement Therapy Use in Cohort Studies: Assessment, Prevalence, and Definitions

 

View this table:

[in a new window]
 
Appendix Table 3. Reasons for Poor Quality Rating and Exclusion from Meta-Analyses

 

View this table:

[in a new window]
 
Appendix Table 4. Cardiovascular Disease Mortality and Hormone Replacement Therapy

 

View this table:

[in a new window]
 
Appendix Table 5. Coronary Artery Disease Mortality and Hormone Replacement Therapy

 

View this table:

[in a new window]
 
Appendix Table 6. Cardiovascular Disease Incidence and Hormone Replacement Therapy

 





 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2002 by the American College of Physicians.